Temozolomide Chemotherapy in Patients with Recurrent Malignant Gliomas

Numerous studies have demonstrated the clinical activity of temozolomide, a second-generation alkylating agent, against malignant brain tumors, however, its activity has not been reported in an Asian population. This study analyzed the efficacy and toxicity of temozolomide in 25 adult patients with...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Yang, Seung-Ho, Kim, Moon-Kyu, Lee, Tae-Kyu, Lee, Kwan-Sung, Jeun, Sin-Soo, Park, Chun-Kun, Kang, Joon-Ki, Kim, Moon-Chan, Hong, Yong-Kil
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: The Korean Academy of Medical Sciences 2006
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2729901/
https://ncbi.nlm.nih.gov/pubmed/16891823
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2006.21.4.739
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak